Associations of residents receiving concomitant use of CYP2D6-metabolized opioids with existing CYP2D6-inhibiting antidepressants (study group) vs. CYP2D6-neutral antidepressants (comparison group) with opioid-related adverse outcomes.
收藏Figshare2025-06-02 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Associations_of_residents_receiving_concomitant_use_of_CYP2D6-metabolized_opioids_with_existing_CYP2D6-inhibiting_antidepressants_study_group_vs_CYP2D6-neutral_antidepressants_comparison_group_with_opioid-related_adverse_outcomes_/29214704
下载链接
链接失效反馈官方服务：
资源简介：
Associations of residents receiving concomitant use of CYP2D6-metabolized opioids with existing CYP2D6-inhibiting antidepressants (study group) vs. CYP2D6-neutral antidepressants (comparison group) with opioid-related adverse outcomes.
创建时间：
2025-06-02
